Dépôt numérique
RECHERCHER

Oral administration of BCG as an adjuvant to surgical treatment of carcinoma of the bronchus

Miller, Anthony; Taylor, Harold E; Baker, Michael A.; Dodds, D.J.; Falk, Rudolph E; Frappier, Armand; Hill, D.P.; Jindani, Amina; Landi, Silvio; MacDonald, A.S.; Thomas, Johnson Wallace; Wall, Claus (1979). Oral administration of BCG as an adjuvant to surgical treatment of carcinoma of the bronchus Canadian Medical Association Journal , vol. 121 . p. 45-54. (Non Publié)

Ce document n'est pas hébergé sur EspaceINRS.

Résumé

A controlled clinical trial of the value of bacille Calmette-Guérin (BCG) vaccine given orally to patients with resectable carcinoma of the lung was conducted in 18 centres across Canada. A total of 308 patients were included in the analysis. 155 in the BCG group and 153 in the control group. The two groups were similar at the time of admission to the trial. BCG (120 mg) was given orally at weekly intervals for 1 month, every 2 weeks up to 3 months and then every 3 months until the total duration of therapy was 18 months.

Type de document: Article
Informations complémentaires: Recueil de tiré-à-part de la bibliothèque: A01132
Mots-clés libres: bcg; carcinome; poumon; vaccin
Centre: Centre INRS-Institut Armand Frappier
Date de dépôt: 08 févr. 2020 19:28
Dernière modification: 08 févr. 2020 19:28
URI: http://espace.inrs.ca/id/eprint/8369

Actions (Identification requise)

Modifier la notice Modifier la notice